Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation. - Wikidata - wikimedia - TriplyDB

Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation.

Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation.

http://www.wikidata.org/entity/Q36365180

about

CD44 cell adhesion molecules Menstrual endometrial cells from women with endometriosis demonstrate increased adherence to peritoneal cells and increased expression of CD44 splice variants CD44 in rheumatoid arthritis Cancer Stem Cell Hierarchy in Glioblastoma Multiforme Roles of Proteoglycans and Glycosaminoglycans in Wound Healing and Fibrosis Lymphopoiesis and matrix glycoprotein SC1/ECM2.Serum CD44 in non-Hodgkin's lymphoma.Molecular studies into the role of CD44 variants in metastasis in gastric cancer.N-Glycans on the link domain of human HARE/Stabilin-2 are needed for hyaluronan binding to purified ecto-domain, but not for cellular endocytosis of hyaluronan A hyaluronan receptor for endocytosis (HARE) link domain N-glycan is required for extracellular signal-regulated kinase (ERK) and nuclear factor-κB (NF-κB) signaling in response to the uptake of hyaluronan but not heparin, dermatan sulfate, or acety The CD44-initiated pathway of T-cell extravasation uses VLA-4 but not LFA-1 for firm adhesion.Terminal sialic acids on CD44 N-glycans can block hyaluronan binding by forming competing intramolecular contacts with arginine sidechains.Proinflammatory stimuli regulate endothelial hyaluronan expression and CD44/HA-dependent primary adhesion Inhibition of CD44 N- and O-linked glycosylation decreases endometrial cell lines attachment to peritoneal mesothelial cells.Hyaluronan-CD44 interactions as potential targets for cancer therapy.CD44 and HCELL: preventing hematogenous metastasis at step 1.Revealing the Mechanisms of Protein Disorder and N-Glycosylation in CD44-Hyaluronan Binding Using Molecular Simulation CD44 deficiency leads to enhanced neutrophil migration and lung injury in Escherichia coli pneumonia in mice Structural variability of CD44v molecules and reliability of immunodetection of CD44 isoforms using mAbs specific for CD44 variant exon products.Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons.Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan.Glycosylation provides both stimulatory and inhibitory effects on cell surface and soluble CD44 binding to hyaluronan Glycosylation of CD44 negatively regulates its recognition of hyaluronan.A cysteine residue located in the transmembrane domain of CD44 is important in binding of CD44 to hyaluronic acid.The role of CD44 in fetal and adult hematopoietic stem cell regulation.Binding of Hyaluronan to the Native Lymphatic Vessel Endothelial Receptor LYVE-1 Is Critically Dependent on Receptor Clustering and Hyaluronan Organization Anticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor.Growth as a solid tumor or reduced glucose concentrations in culture reversibly induce CD44-mediated hyaluronan recognition by Chinese hamster ovary cells.Rheostatic signaling by CD44 and hyaluronan.Does DG42 synthesize hyaluronan or chitin?: A controversy about oligosaccharides in vertebrate development.Hyaluronan: a simple polysaccharide with diverse biological functions.CD44 is not an adhesive receptor for osteopontin.Hyaluronan bound to CD44 on keratinocytes is displaced by hyaluronan decasaccharides and not hexasaccharides.Role of EGR1 in regulation of stimulus-dependent CD44 transcription in B lymphocytes Two different functions for CD44 proteins in human myelopoiesis Ligation of CD44 with low-molecular-weight hyaluronan and a monoclonal antibody leads to inhibition of drug-induced apoptosis in a human myeloid cell line.SHAP potentiates the CD44-mediated leukocyte adhesion to the hyaluronan substratum.CD44 stimulation by fragmented hyaluronic acid induces upregulation of urokinase-type plasminogen activator and its receptor and subsequently facilitates invasion of human chondrosarcoma cells.Up-regulation of the tumour-associated marker CD44V6 in experimental kidney disease.Atomistic fingerprint of hyaluronan-CD44 binding.

P2860

Q24568164-381E3F67-6742-4CFD-9519-58320BB616FB Q24628704-7B78E6D8-D25E-4E13-A7AE-9C772CA47357 Q24804352-7298579A-D227-4F94-BFED-57E24052DCF6 Q26752312-B0882C70-3038-471B-94E1-A6F3541E81D3 Q26786042-DEA6BD0A-46E3-4914-A760-28BE89F1AC1F Q33536274-6C5A29E2-1E8B-488E-AF93-5F7FC112DA3A Q33643978-966C9FA9-3D51-42AE-8F9D-3129D6B66F26 Q33706667-D4ABB81E-56F7-453D-B9A8-0C21EAA0D95E Q33955772-CCBCCDB9-03BE-415D-882B-1A5E367D5E1A Q34070308-C95A6AFE-8F6E-415E-B4F7-EA776BD91BD6 Q34075924-4F020B02-2ADD-4138-B133-0ED0161C9B8A Q34389239-14497F3D-79E7-42DE-8B9A-6152B5C95561 Q34451438-2A1FD664-5033-4175-B221-05A99B6DF8FB Q34516524-77E4ADCC-B90B-4FEA-977A-78B81F403651 Q35194441-D3B27A2A-69D7-4581-BAFA-79D2410F737C Q35376738-A429E372-6E55-4637-AE6C-DBD167956291 Q35746730-6785435D-0881-4734-9AE6-98D411559067 Q35748226-0D1E670D-4B26-4764-98EA-DD47808B1535 Q35754653-FB4CC64F-9988-4C7E-8031-C4366CFD1F40 Q36236359-73598EB3-F25A-4BA6-9733-9DBEC1D703A8 Q36236582-0B7639B1-8A2A-4F28-88B4-9DD950684C44 Q36254851-B058DC8C-F79D-46A6-9EBD-EA9BA8625F9E Q36365225-DAD77044-6984-47AF-ACF3-2DB7611CF11A Q36366743-27491CF4-114F-4F63-AB1E-F8554C7EA28C Q36420731-6AFC706E-1F7B-4B44-8FF9-C439090ED8B7 Q36778808-CE0D52DF-0465-4E95-ADFE-1C639367CED3 Q37188974-8330AC54-5A18-4C19-9ABF-71CC56650B28 Q37371968-764E0658-88CB-4A89-994C-7B9F1FCB830F Q37378764-1E3D9A3B-0DEE-49D7-82A0-06EB2A963CCB Q37596019-81684B3C-C86F-470C-9902-061E98BEC515 Q37649833-41B28667-4139-4626-9B28-C26FA562EAA4 Q38326853-81218CB4-E937-4883-8386-9E817B3904E7 Q38332197-329D1D16-9D65-414A-8C6B-5C7EE2F88B4C Q38358476-0A5C55AD-D108-46B6-9983-2DC863BA1432 Q39809019-1B557EDD-1342-4BD0-AE65-98F694DE7837 Q39820261-6574DB65-E47D-4747-8D88-56A9D269AA83 Q40279635-35CA4663-1FF4-495F-9F4E-025BA1917126 Q40694018-A051394C-6C9C-48A4-82B7-DDC2275E7E25 Q40857184-68F71ABB-A679-42D9-9846-E8E05202756D Q41323711-2D7EC08F-D2A0-42D9-89F3-14ABF15A92EA

P2860

Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation.

http://www.wikidata.org/entity/Q36365180

description

1995 nî lūn-bûn

@nan

1995年の論文

@ja

1995年学术文章

@wuu

1995年学术文章

@zh-cn

1995年学术文章

@zh-hans

1995年学术文章

@zh-my

1995年学术文章

@zh-sg

1995年學術文章

@yue

1995年學術文章

@zh

1995年學術文章

@zh-hant

name

Variant cell lines selected fo ...... differences in glycosylation.

@ast

Variant cell lines selected fo ...... differences in glycosylation.

@en

type

label

Variant cell lines selected fo ...... differences in glycosylation.

@ast

Variant cell lines selected fo ...... differences in glycosylation.

@en

prefLabel

Variant cell lines selected fo ...... differences in glycosylation.

@ast

Variant cell lines selected fo ...... differences in glycosylation.

@en

P1433

Q36365180-2545BDA9-9091-444A-A703-9E25E1B66F0C

P1476

Q36365180-5580FB75-F208-4455-8C0A-2D8E077053D0

P2093

Q36365180-3ADC8EFB-633E-4A2F-B359-1B4A4E6FDFC6

Q36365180-497C87FE-5848-4329-8A30-5F6BC500DD20

Q36365180-5FE87139-764F-42C6-AADC-8D992596EDD9

Q36365180-A5AA9F84-E127-478F-82C2-8D1DEAAC24F5

Q36365180-EEB21E94-A89F-4E78-9E55-A7913269DDB0

P2860

Q36365180-0624A97C-84AF-4EB6-913B-7EE95CE6FCCA

Q36365180-1361914B-8D9F-43FC-96C7-FA55AE528B92

Q36365180-22FF5C8C-3BB8-43A9-88B8-13915FB61F67

Q36365180-28F795F0-851C-4533-A275-8FE73ADAA2A5

Q36365180-33915A13-8A3C-4D2C-9482-F1E07B6DD43A

Q36365180-37598359-D9E2-4C08-AEC8-C1E59D525D7E

Q36365180-386C0A45-4C52-4A93-8C8E-43CC41AC0412

Q36365180-3B2BB08C-C080-4E75-BF4F-602A8557AA9E

Q36365180-569B7267-996C-40E8-980A-90B59F3EAACA

Q36365180-6D48A1AC-8037-447D-B18C-0F33DC866F35

P304

Q36365180-16939BAC-4DB5-4D14-B382-E7D966E10F86

P31

Q36365180-B7B2CCF1-8DC7-4D5E-83C6-25D173185371

P356

Q36365180-D0057A59-4520-490D-A6C6-674BED760F6B

P407

Q36365180-8E087E59-559D-4391-8EA8-750D54CBA7E2

P433

Q36365180-33EB6B31-4F60-409B-B6EE-49F253778CA9

P478

Q36365180-EF0A2070-4956-417C-9DD9-182F3401CAD2

P577

Q36365180-A627FB2C-5457-48CA-81EE-A636D2D6E33A

P5875

Q36365180-2E693A15-EFC7-436F-9F2A-9D2EDEE70ECF

P698

Q36365180-92CA2A82-1368-44F7-B195-04621B705885

P921

Q36365180-6656FC05-5701-485F-BD0D-D0D4A2F53C85

P932

Q36365180-A9BDEE40-3B66-422B-B6E2-9FF5930BB77B

P356

P1433

Journal of Experimental Medicine

P1476

Variant cell lines selected fo ...... differences in glycosylation.

@en

P2093

A Perschl

http://www.w3.org/2001/XMLSchema#string

J Gregoroff

http://www.w3.org/2001/XMLSchema#string

J Lesley

http://www.w3.org/2001/XMLSchema#string

N English

http://www.w3.org/2001/XMLSchema#string

R Hyman

http://www.w3.org/2001/XMLSchema#string

P2860

A novel secretory tumor necrosis factor-inducible protein (TSG-6) is a member of the family of hyaluronate binding proteins, closely related to the adhesion receptor CD44

CD44 is the principal cell surface receptor for hyaluronate

Molecular isoforms of murine CD44 and evidence that the membrane proximal domain is not critical for hyaluronate recognition

The chondroitin sulfate form of invariant chain can enhance stimulation of T cell responses through interaction with CD44.

CD44: the hyaluronan receptor.

Requirements for hyaluronic acid binding by CD44: a role for the cytoplasmic domain and activation by antibody.

Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long-term bone marrow cultures

Correlation of CD2 binding and functional properties of multimeric and monomeric lymphocyte function-associated antigen 3.

Hyaluronan binding function of CD44 is transiently activated on T cells during an in vivo immune response

Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development.

P304

431-437

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.182.2.431

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

182

http://www.w3.org/2001/XMLSchema#string

P577

1995-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

274440884

http://www.w3.org/2001/XMLSchema#string

P698

7543138

http://www.w3.org/2001/XMLSchema#string

P921

P932

2192117

http://www.w3.org/2001/XMLSchema#string